These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 12368155)

  • 21. Simultaneous expression of CD38 and its ligand CD31 by chronic lymphocytic leukemia B-cells: anecdotal observation or pathogenetic hypothesis for the clinical outcome?
    Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F
    Haematologica; 2003 Mar; 88(3):354-5. PubMed ID: 12651280
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
    D'Arena G; Tarnani M; Rumi C; Vaisitti T; Aydin S; De Filippi R; Perrone F; Pinto A; Chiusolo P; Deaglio S; Malavasi F; Laurenti L
    Am J Hematol; 2007 Sep; 82(9):787-91. PubMed ID: 17534928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression levels of CD38 on leukemic B cells but not on non-leukemic T cells are comparably stable over time and predict the course of disease in patients with chronic lymphocytic leukemia.
    Eisele L; Haddad T; Sellmann L; Dührsen U; Dürig J
    Leuk Res; 2009 Jun; 33(6):775-8. PubMed ID: 18922578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features and outcome of Chinese patients with monoclonal B-cell lymphocytosis.
    Xu W; Li JY; Wu YJ; Cao X; Fan L; Qiao C; Liu Q; Yao L; Miao KR
    Leuk Res; 2009 Dec; 33(12):1619-22. PubMed ID: 19250675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD31 density is a novel risk factor for patients with B-cell chronic lymphocytic leukaemia.
    Mainou-Fowler T; Porteous A; Nicolle A; Proctor SJ; Anderson JJ; Summerfield G
    Int J Oncol; 2008 Jul; 33(1):169-74. PubMed ID: 18575763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia.
    Del Giudice I; Morilla A; Osuji N; Matutes E; Morilla R; Burford A; Maravelaki S; Owusu-Ankomah K; Swansbury J; A'Hern R; Brito-Babapulle V; Catovsky D
    Cancer; 2005 Nov; 104(10):2124-32. PubMed ID: 16211545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Importance of prognostic factors in patients with chronic B-lymphocytic leukemia at the time of diagnosis].
    Cmunt E; Michalová K; Sindelárová L; Karban J; Zemanová Z; Kurková S; Brezinová J; Schwarz J; Bosáková Z
    Sb Lek; 2002; 103(3):359-70. PubMed ID: 12688180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia.
    Ahmad E; Steinberg SM; Goldin L; Hess CJ; Caporaso N; Kreitman RJ; Wiestner A; Wilson W; White T; Marti G; Stetler-Stevenson M
    Cytometry B Clin Cytom; 2008 Jul; 74(4):221-6. PubMed ID: 18431797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders.
    Eclache V; Caulet-Maugendre S; Poirel HA; Djemai M; Robert J; Lejeune F; Raphaël M
    Cancer Genet Cytogenet; 2004 Jul; 152(1):72-6. PubMed ID: 15193446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses.
    Scielzo C; Ghia P; Conti A; Bachi A; Guida G; Geuna M; Alessio M; Caligaris-Cappio F
    J Clin Invest; 2005 Jun; 115(6):1644-50. PubMed ID: 15931393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
    Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
    Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study.
    Bairey O; Ruchlemer R; Rahimi-Levene N; Herishanu Y; Braester A; Berrebi A; Polliack A; Klepfish A; Shvidel L;
    Ann Hematol; 2011 Oct; 90(10):1123-9. PubMed ID: 21614458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination.
    Rutella S; Rumi C; Puggioni P; Barberi T; Di Mario A; Larocca LM; Leone G
    Haematologica; 1999 May; 84(5):419-24. PubMed ID: 10329920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.
    Rossi D; Sozzi E; Puma A; De Paoli L; Rasi S; Spina V; Gozzetti A; Tassi M; Cencini E; Raspadori D; Pinto V; Bertoni F; Gattei V; Lauria F; Gaidano G; Forconi F
    Br J Haematol; 2009 Jun; 146(1):64-75. PubMed ID: 19438485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum level of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemia.
    Molica S; Digiesi G; Mirabelli R; Cutrona G; Antenucci A; Molica M; Giannarelli D; Sperduti I; Morabito F; Neri A; Baldini L; Ferrarini M
    Eur J Haematol; 2009 Sep; 83(3):208-14. PubMed ID: 19459926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.
    Mauro FR; Gentile M; Mancini F; Giannarelli D; Guarini A; De Propriis MS; Cerretti R; Foa R
    Haematologica; 2002 Jun; 87(6):602-8. PubMed ID: 12031916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and immunologic aspects of B chronic lymphocytic leukemia associated with autoimmune disorders.
    Duek A; Shvidel L; Braester A; Berrebi A
    Isr Med Assoc J; 2006 Dec; 8(12):828-31. PubMed ID: 17214095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia.
    Shen PU; Fuller SG; Rezuke WN; Sherburne BJ; DiGiuseppe JA
    Am J Clin Pathol; 2001 Dec; 116(6):905-12. PubMed ID: 11764081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil.
    Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F
    Haematologica; 2002 Feb; 87(2):217-8. PubMed ID: 11836173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and prognostic evaluation of bone marrow infiltration (biopsy versus aspirate) in early chronic lymphocytic leukemia. A single center study.
    Molica S; Tucci L; Levato D; Docimo C
    Haematologica; 1997; 82(3):286-90. PubMed ID: 9234573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.